score/[id]

/
CLASSIFICATION
Classification
ITBCG tumor budding (BD1–BD3)
International Tumor Budding Consensus Conference (2016) grading of tumor buds at the invasive front of colorectal cancer. Count in one 0.785 mm² hotspot.
Classification overview
ITBCG
BD1 · Low budding (0–4 buds)
BD2 · Intermediate budding (5–9 buds)
BD3 · High budding (≥10 buds)
Method · Counting method
ITBCG
BD1
Low budding (0–4 buds)
Count
0–4 buds in one hotspot (0.785 mm²) at the invasive front
Reporting
Selective reporting acceptable in many protocols
Prognosis
Favourable compared with BD2/BD3
BD2
Intermediate budding (5–9 buds)
Count
5–9 buds in one hotspot at the invasive front
Reporting
Mandatory reporting recommended (ITBCC)
Prognosis
Intermediate adverse prognostic factor
BD3
High budding (≥10 buds)
Count
≥10 buds in one hotspot at the invasive front
Reporting
Mandatory reporting recommended (ITBCC)
Prognosis
High risk of LNM and poor outcome; may influence adjuvant therapy
Note: Associated with higher LNM risk in T1 colorectal cancer. Separate from the Kajiwara nomogram.
Method
Counting method
Bud
Single cell or cluster of ≤4 cells
Hotspot
0.785 mm² field at invasive front (20×, 0.5 mm diameter)
Stain
H&E (ITBCC standard)
Report an issue or feedback
Do not enter identifiable patient information or patient images.
Decision support only. Follow current guidelines and local protocols. Classification definitions and terminology follow the original publication language.